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Hepatic ischemic/reperfusion injury (HIRI) is a major complication of liver resection and
transplantation. Octreotide, a somatostatin analogue, has been used to treat hepatic
ﬁbrosis and portal hypertension; however, its function against HIRI remains unclear. To
elucidate the effect of octreotide in HIRI, we investigated the hepatocellular protein
proﬁles in response to octreotide preconditioning in a rabbit model by using proteomic
analysis. Twenty-four rabbits were divided into 3 groups: the sham operative group (con-
trol), the ischemia/reperfusion group (IR), and the ischemia/reperfusion þ octreotide
group (IRþOct). They were subjected to 30 minutes of normothermic ischemia followed
by 120 minutes of reperfusion by using Pringle’s maneuver method. Proteomic studies
were then performed to compare the protein proﬁles of their left liver lobe. A total of 16
differential proteins were successfully identiﬁed. These ﬁndings suggest that octreotide
might exert an effect against HIRI through up-regulating the expression of the anti-injury
substances, such as heat-shock proteins 70 and 27 (conﬁrmed by using Western blot
analysis); signiﬁcantly raising the phosphatidylethanolamine-binding protein that alleviates
IR-related apoptosis; and down-regulating mitochondrial metabolic enzymes such as
NADH2 dehydrogenase and triosephosphate isomerase.This study was funded by Hunan Provincial Science and
Technology Bureau of China (06SK3079, 2007FJ3081).
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Changsha, Hunan 410013. E-mail: 315977705@qq.comHEPATIC ischemic/reperfusion injury (HIRI) is a majorcause of morbidity and mortality after vascular
exclusion in liver and liver transplantation surgery. Ischemic
preconditioning, which could improve clinical outcomes
after HIRI [1], is an adaptional phenomenon in which
tissues are rendered resistant to the deleterious effects of
ischemia/reperfusion (IR), either by previous exposure to
brief periods of vascular occlusion or by the administration
of certain chemical agents. Ischemic preconditioning might
exert its protective effects through transient nitric oxide
production, diminution of toxic reactive species, preserva-
tion of energy metabolism during ischemia, and involvement
of nuclear transcription factor and others [2e5].
Octreotide, a synthetic analogue of somatostatin, was
approved for use by FDA in 1988. It was primarily used to
improve the management of carcinoid and VIPomas [6e8].
Since then, research studies and clinical experience have
accumulated that suggest a potentially much broader ther-
apeutic role for octreotide. Octreotide is now used for
treating pituitary tumors, gastroenteropancreatic tumors,
diabetes mellitus, pancreatitis, complications of pancreatic4
.org/10.1016/j.transproceed.2014.06.071surgery and transplantation, and short bowel syndrome
[9e11]. Other indications for its use include hypercalcemia,
cancer-related pain, polycystic ovary syndrome, and certain
cancers. Octreotide inhibits hepatic ﬁbrosis, bile duct pro-
liferation, and bacterial translocation in obstructive jaundice
[12]. It could cause strong hepatic glucose release even
under hypoxic-ischemic conditions in rat livers with ﬁlled
glycogen stores [13]. It may also protect the liver against
HIRI [14].
In our previous studies, we showed that octreotide could
protect the liver against HIRI in a rabbit model. Liver func-
tion can be protected and hepatocellular apoptosis decreasedª 2014 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY-NC-SA license (http://
creativecommons.org/licenses/by-nc-sa/3.0/).
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HEPATOCELLULAR PROTEIN PROFILES 3283by reducing endotoxin production and down-regulating the
inﬂammatory cytokines tumor necrosis factorea and inter-
leukin-1b [15]. However, those results are not enough to
clarify octreotide’s mechanism of action regarding HIRI.
Proteomic studies of IR samples represent an important step
toward a better understanding of the disease and may lead
to identiﬁcation of clinically useful markers [16]. Methodo-
logic advances in proteomics allowed the comparison of the
protein content in different IR and octreotide-treated IR
samples, using gel or liquid-based approaches coupled with
mass spectrometry [17]. Proteomic studies have the advan-
tage of being able to discern changes in expression levels and
help elucidate the underlying mechanism [18].
The goal of the present study was to investigate the
mechanisms of HIRI and protective mechanisms of octreo-
tide on HIRI. We evaluated the hepatocellular protein
proﬁles after HIRI with or without octreotide precondition-
ing in a rabbit model and identiﬁed some potential proteins by
using a proteomic-based approach.MATERIALS AND METHODS
Animals Preparation
All institutional and national guidelines for the care and use of
laboratory animals were followed. Twenty-four New Zealand rab-
bits of both sexes, weighing 1.6 to 1.9 kg, were used in this study. All
animals were obtained from the Laboratory Animal Center of
Xiangya Medical School of Central South University. All experi-
mental procedures and study design were reviewed and approved by
the Institutional Animal Care Committee of Xiangya Medical
School of Central South University, China.
HIRI Model
All rabbits were fasted for 12 hours before the experiment but were
given free access to water. Twenty-four rabbits were randomly
divided into 3 equal groups: the sham-operated group (control), the
IR group (IR), and the IR þ octreotide pretreatment group
(IRþOct). Each rabbit was anesthetized with an intraperitoneal
injection of 3% pentobarbital sodium (30 mg/kg). After the induc-
tion of anesthesia, an intravenous line was established in an ear vein
and a 0.9% saline solution infusion was begun at 10 mL/kg per hour.
The animal then underwent a tracheotomy and was mechanically
ventilated (DH-150 Animal Ventilator, Zhejiang University Medi-
cal Apparatus Ltd., Zhejiang, China) on 100% oxygen with a tidal
volume of 10 mL/kg. Anesthesia was maintained by a continuous
infusion of fentanyl at 10 mg/kg per hour and intermittent admin-
istrations of 3% pentobarbital (10 mg/kg). Vecuronium was infused
at 0.1 mg/kg per hour to maintain relaxation.
Thirty minutes before laparotomy, the IRþOct group rabbits
received an injection of octreotide (Jilin Province A-Think Phar-
maceutical Co., Ltd., Jilin, China) 20 ug/kg intraperitoneally and 30
ug/kg subcutaneously. Control and IR group rabbits received the
same volume isotonic saline, and all rabbits underwent a laparot-
omy. HIRI models were set up in the IR and IRþOct groups by
using Pringle’s method [19], which consisted of ischemia for 30
minutes followed by reperfusion for 120 minutes. All animals were
killed, and the left liver lobe of each rabbit was removed and ﬁxed in
liquid nitrogen and then stored at 80C for protein proﬁles
analysis.Two-Dimensional Electrophoresis
Eighty milligrams of rabbit liver left lobe tissues of each group were
lysed in 400 uL of lysis buffer (urea 7 mol/L, thiourea 2 mol/L, DTT
100 mmol/L, 4% CHAPS, Tris 40 mmol/L, 2% Pharmalyte, 1
mg/mL DNase I) at 37C for 1 hour and then centrifuged at 15,000
rpm for 30 minutes at 4C. The supernatant was transferred and
the concentration of the total proteins was determined by using a
2-dimensional quantiﬁcation kit (Amersham Biosciences, Sweden).
Two-dimensional electrophoresis (2-DE) was performed to sepa-
rate 800-mg protein samples, as described by Feng et al [19]. After
sodium dodecyl sulfateepolyacrylamide gel electrophoresis, the
protein spots were visualized by staining with colloidal Coomassie
(Bio-Rad Laboratories, Minneapolis, Minn, United States). Tripli-
cate gels were made for each cell line.
Image Analysis
To minimize the contribution of experimental variations, 3 separate
2-dimensional gels were prepared for each tissue. The stained
2-dimensional gels were scanned with the MagicScan software on
ImageScanner (Amersham Biosciences, Uppsala, Sweden) and
were analyzed by using the PDQuest system (Bio-Rad Laboratories,
California, United States). Spot intensities were quantiﬁed by
calculating the spot volume after normalization of the image using
the total spot volume normalization method multiplied by the total
area of all the spots. An average 2-DE map for each group was
constructed with the PDQuest image analysis software after spot
matching, and the expression level of a protein spot was determined
by its average intensity volume of 3 gels. The average 2-DE maps
were used to perform the various expression analysis. The differ-
ences of the matched protein spots between the tissues was calcu-
lated by the ratio of their average expression levels, and proteins
were classiﬁed as being differentially expressed between the tissues
when average spot intensity was showed a difference 2-fold vari-
ation. Signiﬁcant differences in protein expression levels were
determined by the Student t test with a set value of P < .05.
Mass Spectrometry Analysis
All the differential protein spots exhibiting consistent differences
between the tissues in triplicate experiments were excised from
stained gels using punch, in-gel trypsin digested. They were
analyzed with a Voyager System DE-STR 4307 matrix-assisted laser
desorption/ionizationetime-of-ﬂight (MALDI-TOF) mass spec-
trometry (MS) to produce a peptide mass ﬁngerprint as previously
described by Feng et al [19]. The protein spots identiﬁed according
to MALDI-TOF MS were also subjected to analysis of electrospray
ionization quadrupole time-of-ﬂight MS (Micromass, Waters Cor-
poration, Milford, Mass, United States). Brieﬂy, the samples were
loaded onto a precolumn (320 mm  50 mm, 5-mm C18 silica beads;
Waters Corporation) at 30 mL/min ﬂow rates for concentrations and
fast desalting through a Waters CapLC autosampler and then
eluted to the reversed-phase column (75 mm  150 mm, 5 mm,
100Å; LC Packing) at a ﬂow rate of 200 nL/min after ﬂow splitting
for separation. MS/MS spectra were performed in data-depended
mode in which up to 4 precursor ions above an intensity
threshold of 7 counts per second were selected for MS/MS analysis
from each survey “scan.”
Western Blot Analysis
Western blot analysis was performed to detect the expression of
heat-shock protein (HSP) 70 and HSP27 in the frozen liver tissues,
as previously described by Feng et al [19]. Brieﬂy, 40 mg of lysates
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electrophoresis and transferred to a polyvinylidene diﬂuoride
membrane. Blots were blocked with 5% nonfat dry milk for 2 hours
at room temperature and then incubated with 1:1000 dilution of
monoclonal mouse antieHSP70 antibody (Santa Cruz Biotech-
nology, Santa Cruz, Calif, United States), 1:3000 dilution of mono-
clonal mouse anti-HSP27 antibody (Santa Cruz Biotechnology,
Santa Cruz, California, United States) for 2 hours at room tem-
perature, and then by incubation with 1:3000 dilution of horseradish
peroxidaseeconjugated secondary antibody for 1 hour at room
temperature. The signal was visualized with an enhanced chem-
iluminescence detection reagent. b-actin was detected simulta-
neously by using 1:3000 dilution of monoclonal mouse antieb-actin
antibody (Santa Cruz Biotechnology, Santa Cruz, California, United
States), as a loading control. Three independent experiments were
conducted.
Database Search
In peptide mass ﬁngerprint map database searching, Mascot
Distiller was used to obtain the monoisotopic peak list from the raw
mass spectrometry ﬁles. Peptide matching and protein searches
against the Swiss-Prot database were performed by using the
Mascot search engine (http://www.matrixscience.com/) with a mass
tolerance of 50 ppm. Protein scores of >64 (threshold) indicate
identity or extensive homology (P < .05) and were considered sig-
niﬁcant. In the tandem mass spectrometry data database query, the
MS/MS data (PKL format ﬁle) was imported into the Mascot search
engine with a MS/MS tolerance of 0.3 Da to search the Swiss-Prot
database. For the protein matching of 2 unique peptides, indi-
vidual ion scores of >28 (threshold) indicate identity or extensive
homology (P < .05) and were considered signiﬁcant. For the protein
matching only 1 unique peptide, individual ion scores of >35
(threshold) indicate identity or extensive homology (P < .05) and
were considered signiﬁcant.
RESULTS
Screening for HIRI-Octreotide Associated Proteins by 2-DE
A comparative proteomic study of the IR, IRþOct, and
control rabbits was conducted to identify proteins involved in
the octreotide-associated HIRI process. Two representative,
high-resolution 2-dimensional maps (pH 3e10 gradient)
from liver tissues of 3 groups were demonstrated in Fig 1. In
total, 1012  29, 1007  34, and 1019  26 protein spots
were separated and visualized respectively. The match rates
were 92.8%, 94.2%, and 91.6%. We analyzed and com-
pared quantitatively 2-DE using PDQuest image analysisFig 1. Representative 2-dimensional
electrophoresis (2-DE) maps (pH 3e10
gradient) in 3 groups: (A) sham operative
group (control); (B) ischemia/reperfusion
group (IR); and (C) the ischemia/
reperfusion þ octreotide group (IRþOct).and found 31 differentially expressed proteins, including
the expression level of 16 proteins such as HSP70.
Phosphatidylethanolamine-binding proteins (PEBPs) were
up-regulated and 11 proteins were down-regulated in the
IRþOct group compared with the control group. Six pro-
teins were elevated and 4 proteins were decreased in the
IRþOct group compared with the IR group. Representative
protein spots identiﬁed by MALDI-TOF-MS are shown in
Fig 2. Spots 5, 6, 15, 16, 20 were up-regulatedin the ischemia/
reperfusion+octreotide group than in the ischemia/reper-
fusion group and the control group.
Proteins Identiﬁed by Using MALDI-TOF-MS
After comparing the average 2-DE maps, differential pro-
tein spots (2-fold) were detected and subjected to the
analysis of MALDI-TOF MS. Then, peptide matching and
protein searches against the Swiss-Prot database were per-
formed by using the Mascot search engine. 16 differential
proteins were successfully identiﬁed. The MS/MS results of
spot 5 are shown in Fig 3. The database search results
showed that the access number of spot 5 in Swiss-Prot
database is BAB18615 and its molecular weight is 53,484.
Thus, the protein spot 5 was identiﬁed as HSP70. Table 1
summarizes the additional information for all the proteins
identiﬁed.
These proteins were metabolism enzymes involving
mitochondrial, molecular chaperone, antiapoptotic proteins
and other proteins, or initiation factors involving cellular
structures, signal transduction and transcript translation.
Validation of HSP27 and HSP70 by Western Blot Analysis
To verify the expression of differential proteins screened by
proteomic analysis, we selected 2 proteins, HSP70 (protein
spot 5) and HSP27 (protein spot 30), whose expression
exhibited signiﬁcant differences between the IRþOct group
and the control group and detected their expression level ac-
cording toWestern blot analysis. As demonstrated in Fig 4, the
expression levels ofHSP70 were signiﬁcantly elevated (4.5-fold
higher in the IR group and 9.3-fold higher in the IRþOct
group than that in the control group). Meanwhile, the
expression ofHSP27was up-regulated 7.2-fold higher in the IR
group and 10.9-fold higher in the IRþOct group than in the
control group. More importantly, the expression levels of
HSP27 and HSP70 were promoted in the IRþOct group by
Fig 2. Representative discrepancy pro-
tein spots identiﬁed by matrix-assisted
laser desorption/ionizationetime-of-ﬂight
(MALDI-TOF) mass spectrometer (MS).
Proteins spots were zoomed and showed
that the expression level of (A) spots 5,
15, 16, and (B) spots 6 and 20 were
up-regulated more in the ischemia/
reperfusion þ octreotide group (IRþOct)
than in the ischemia/reperfusion (IR) group
and the control group.
HEPATOCELLULAR PROTEIN PROFILES 3285more than 2.0- and 1.5-fold, respectively, than that in the IR
group, which is consistent with the results from proteomic
analysis. These ﬁndings imply that HSP27 andHSP70may play
an important role in the protection of octreotide against IR.DISCUSSION
HIRI is a complicated pathophysiological process. It could
result in excessive intracellular calcium [20], increasing free
oxygen radicals in activated neutrophils and Kupffer cells
and apoptosis in liver parenchymal cells [21,22]. Using
proteomics technology, Hirsch et al [23] identiﬁed 1559Fig 3. Database search results of spot
5 heat-shock protein 70. (A) Peptide
matching and protein searches against
the Swiss-Prot database were performed
by using the Mascot search engine, pro-
ducing results of its peptide mass ﬁnger-
print. (B) The top score of spot 5 was
142, serial number was BAB18615; it was
identiﬁed as HSP70.proteins in an HIRI model and found that IR caused certain
inﬂammation-related proteins, such as calgranulin, C3,
myeloperoxidase, copper/zinc superoxide dismutase, and
hydrogen peroxide, to be up-regulated. We also conﬁrmed
that HIRI causes hepatocyte damage, and that octreotide, a
synthetic somatostatin octapeptide, may be a promising
pharmacologic agent for preconditioning against HIRI [7].
In the present study, we investigated the mechanism
of HIRI and the protection mechanism of octreotide by
using a proteomics model. We obtained high-resolution,
reproducible 2-DE maps (pH 3e10 gradient) (Fig 1) of
liver tissues from the 3 groups (control, IR, and IRþOct
Table 1. Differential Expression Proteins Identiﬁed by Mass Spectrometry Between the IR, IRDOct, and Control Groups
No.
Swiss-Prot
Accession No. Protein Name
Molecular
Weight (Da) Scores Function
Expression Ratio
IR:Control IRþOct:Control
2 AAH22368 NADH-ubiquinone oxidoreductase 79,465 161 Metabolism Y0.4 [3.5
3 Q5VWY1 Mitochondrial short-chain enoyl-coenzyme A 31,367 80 Fatty acid b-oxidation [2.6 Y0.3
5 BAB18615 Heat-shock protein 70 70 kD 128 Chaperone [2.1 [[5.3
6 Q8MK67_RA-BIT Phosphatidylethanolamine-binding protein 21,097 104 Anti-apoptosis [3.3 [[7.4
8 A29821 HSPA5 precursor 72,187 139 Chaperone [[4.2 [3.6
9 AAA67526 Heat-shock protein 9B (mortalin-2) 70,000 98 Chaperone [2.0 [[5.0
10 AAB58347 Envelope glycoprotein 70,895 130 Signal transduction Y0.4 Y0.3
13 Q96E67 ACTB protein 40,194 134 Metabolism [[4.1 [2.3
20 gij999892 Triosephosphate isomerase 26,807 106 Metabolism [2.5 [[4.6
21 gij21730859 Superoxide dismutase 22,295 72 Signal transduction [2.2 [2.8
22 gij31543380 RNA-binding protein 21,142 79 Signal transduction Y0.48 1.6
23 FIHUA Translation initiation factor eIF-5A 16,821 64 Transcript Y0.43 YY0.22
25 Q6GMY0 Keratin 8 53,717 97 Anti-apoptotic Y0.36 1.3
29 Q6IBM4 HNRPH1 protein 49,099 85 Ubiquinone-binding
protein
Y0.45 YY0.22
30 HHHU27 Heat shock protein 27 22,768 98 Molecular chaperone [2.1 [[7.2
31 A33370 Hþ-transporting 2-sector ATPase b-chain
precursor




Abbreviations: [, protein spots that are up-regulated >2-fold compared with the control group; [[, protein spots that are up-regulated >4-fold compared with the
control group; ATP, adenosine triphosphate; Control, sham operative group; IR, ischemia/reperfusion group; IRþOct, ischemia/reperfusion þ octreotide group; RNA,
ribonucleic acid.
3286 YANG, SUN, GUAN ET ALgroups) and compared 2-DE data by using PDQuest image
analysis. We found 31 differentially expressed proteins, 20
up-regulated proteins in the IR group, 17 up-regulated
proteins in the IRþOct group, 7 down-regulated proteinsFig 4. Up-regulation of heat-shock protein (HSP) 70 and HSP2
reperfusion þ octreotide group (IRþOct) group. (A) Western blot ana
HSP27 in response to octreotide treatment. Representative results a
mean band intensity of HSP70 and HSP27 from Western blot image
.0134, lower *P ¼ .0117 upper **P ¼ .0037, lower **P ¼ .0019, *P
ischemia/reperfusion group.in the IR group, and 11 down-regulated proteins in the
IRþOct group. These proteins were then identiﬁed ac-
cording to MALDI-TOF-MS, and a total of 16 differential
expression proteins such as HSP27 and HSP70 were7 were conﬁrmed by Western blot analysis in the ischemia/
lysis was performed to conﬁrm the up-regulation of HSP70 and
re shown from 1 of 3 independent experiments. (B) Summary of
s was plotted on the right. Error bars indicate SE. Upper *P ¼
< .05, **P < .05. Abbreviations: Ctrl, sham operative group; IR,
HEPATOCELLULAR PROTEIN PROFILES 3287successfully identiﬁed. These proteins were metabolism
enzymes involving mitochondria, antiapoptotic proteins,
molecular chaperone, and other proteins or initiation
factors involving cellular structures, signal transduction, and
transcript translation (Table 1).
In this study, the veriﬁed protein spots 2, 3, 13, 20, and 31
were related to material and energy metabolism. Among
them, spot 2 was identiﬁed as NADH-ubiquinone oxidore-
ductase, which is also referred to mitochondrial precursor or
NADH2 dehydrogenase (ubiquinone). It is one of the main
components of the mitochondrial inner membrane respira-
tory chain. NADH-ubiquinone oxidoreductase is also
involved in ATP synthesis by participating oxidative phos-
phorylation of cells as a hydrogen carrier. In addition, protein
spot 20 was triosephosphate isomerase, which could catalyze
glucose to 1,6 diphosphate in glycolysis. Our results showed
that the expression of NADH2 dehydrogenase was signiﬁ-
cantly down-regulated in the IR group; furthermore, the
extent of the down-regulation was bigger in the IRþOct
group compared with the IR group. The expression of tri-
osephosphate isomerase in the IR group was signiﬁcantly up-
regulated; interestingly, the up-regulated magnitude was
bigger in the IRþOct group relative to the IR group. Thismay
be because, after IR injury, the ATP demand increased, and
NADH2 dehydrogenase consumption also increased when
liver cells made up ATP. In addition, the energy supply of
liver cells was mainly produced from aerobic oxidation of
tricarboxylic acid cycle in the IRþOct group, which
compensated with more ATP compared with the IR group
according to glycolysis.
The voltage-dependent anion channels located in the outer
mitochondrial membrane may control the transport of some
ions and metabolites. They regulate mitochondrial-mediated
cell death in 2 main ways: one, as the main components of the
mitochondrial permeability transition pore, and the other
through the interaction with the Bcl-2 family of proteins
[24e26]. Our previous study found that serious mitochondria
damage occurred in the hepatic ischemia-reperfusion pro-
cess, and it was associated with expression of apoptosis-
related proteins such as Bcl-2/Bax [15]. In this study, our
results showed that PEBP from spot 6 was up-regulated in the
IR and IRþOct groups, and that expression of PEBP in the
IRþOct group was much higher by 2.2-fold than that in the
IR group (Table 1). It has been reported by Zhang et al [27]
that PEBP4 could promote mouse cells transposition by
inhibiting the activities of ERK1/2 and JNK and by up-
regulating the express of cyclooxygenase-2; thus, it could
decrease cell apoptosis induced by epirubicin. Based on the
function of PEBP against apoptosis, our ﬁndings suggest that
the apoptosis of liver cells resulting from HIRI might be
related to PEBP. More importantly, the results imply that
octreotide might exert a protective effect against liver cells
apoptosis from HIRI by up-regulating PEBP.
We also showed that the expression levels of HSP70 and
HSP27 were up-regulated in the IR group and the IRþOct
group and were especially higher in the IRþOct group
compared with the control group; this was according toproteomics analysis and was also veriﬁed by Western blot
analysis (Fig 4). HSP is a nonsecreted protein, which is
called a “molecular chaperone” involved in important
physiological activities of the living cell (eg, protein trans-
location, folding and assembly, maintaining cell homeosta-
sis). Consistent with our ﬁndings, HSP70 has undergone
extensive research as an anti-cell damage marker in HIRI
[28,29] and pharmacologic preconditioning models [30,31].
HSP 27 has also been considered as one of the anti-cell
damage markers in cardiac IRI [32,33] and the kidney IRI
model [34]. The elevation of HSP70 and HSP27 suggest that
both might be critical modulates in response to octreotide
preconditioning against HIRI for anti-cell damage. Further
investigation regarding their detailed mechanisms will help
us elucidate the role of octreotide against HIRI.
In conclusion, the mechanism of HIRI and the protection
mechanism of octreotide on HIRI are complicated,
involving the inﬂuence of multiple factors. Our study found
that octreotide may play an important role in the protection
of HIRI through up-regulation of the expression of the anti-
injury substances such as HSP70 and HSP27, signiﬁcantly
raising the PEBP which alleviates IR-related apoptosis, and
down-regulating mitochondrial metabolic enzymes such as
NADH2 dehydrogenase and triosephosphate isomerase.
These ﬁndings strongly support the promise of octreotide
preconditioning for liver and liver transplantation surgery
and also shed some light on the protective mechanism of
octreotide against HIRI.
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